UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging

Oncotarget, 2018-03, Vol.9 (24), p.17181-17198

2018

Link zum Volltext

Verfügbarkeit prüfen

miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment

Cells (Basel, Switzerland), 2020-01, Vol.9 (1), p.220

2020

Link zum Volltext

Verfügbarkeit prüfen

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model

Molecular therapy. Nucleic acids, 2018-06, Vol.11 (C), p.485-493

2018

Link zum Volltext

Verfügbarkeit prüfen

Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance

Biology (Basel, Switzerland), 2023-03, Vol.12 (3), p.449

2023

Link zum Volltext

Verfügbarkeit prüfen

The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies

Frontiers in oncology, 2021-05, Vol.11, p.673506-673506

2021

Link zum Volltext

Verfügbarkeit prüfen

The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma

Genes, 2021-06, Vol.12 (6), p.902

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs Patterns as Potential Tools for Diagnostic and Prognostic Follow-Up in Cancer Survivorship

Cells (Basel, Switzerland), 2021-08, Vol.10 (8), p.2069

2021

Link zum Volltext

Verfügbarkeit prüfen

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation

Oncotarget, 2014-10, Vol.5 (20), p.10034-10047

2014

Link zum Volltext

Verfügbarkeit prüfen

A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin

Neoplasia (New York, N.Y.), 2009-10, Vol.11 (10), p.1064-1073

2009

Link zum Volltext

Verfügbarkeit prüfen

Adenosine receptors and cancer

Biochimica et biophysica acta, 2011-05, Vol.1808 (5), p.1400-1412

2011

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient

Clinical microbiology and infection, 2021-06, Vol.27 (6), p.936-937

2021

Link zum Volltext

Verfügbarkeit prüfen

Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments

Oncotarget, 2018-03, Vol.9 (24), p.17199-17209

2018

Link zum Volltext

Verfügbarkeit prüfen

Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells

Molecular pharmacology, 2007-08, Vol.72 (2), p.395-406

2007

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

British journal of pharmacology, 2012-03, Vol.165 (6), p.1773-1788

2012

Link zum Volltext

Verfügbarkeit prüfen

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia

Oncotarget, 2016-11, Vol.7 (48), p.79842-79853

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract A34: Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL)

Clinical cancer research, 2015-09, Vol.21 (17_Supplement), p.A34-A34

2015

Link zum Volltext

Verfügbarkeit prüfen

The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy

Oncotarget, 2013-09, Vol.4 (9), p.1496-1506

2013

Link zum Volltext

Verfügbarkeit prüfen

A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin

Neoplasia (New York, N.Y.), 2009-10, Vol.11 (10), p.1064

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract B46: Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation

Molecular cancer therapeutics, 2015-07, Vol.14 (7_Supplement), p.B46-B46

2015

Link zum Volltext

Verfügbarkeit prüfen

The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells

Oncotarget, 2015-07, Vol.6 (19), p.17147-17160

2015

Link zum Volltext

Verfügbarkeit prüfen

PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines

Oncotarget, 2017-04, Vol.8 (14), p.23213-23227

2017

Link zum Volltext

Verfügbarkeit prüfen

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia

Oncotarget, 2015-03, Vol.6 (9), p.6597-6610

2015

Link zum Volltext

Verfügbarkeit prüfen

Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia

Oncotarget, 2016-08, Vol.7 (34), p.55690-55703

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3736: The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3736-3736

2012

Link zum Volltext

Verfügbarkeit prüfen

Retracted: Cannabinoid CB 2 receptors modulate ERK‐1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

British journal of pharmacology, 2012-03, Vol.165 (6), p.1773-1788

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(67)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(12)
Oncology
(10)
Cell Biology
(9)
Cell Line, Tumor
(7)
Research Paper
(7)
Review
(7)
Proteins
(6)
Signal Transduction - Drug Effects
(6)
Apoptosis - Drug Effects
(5)
Autophagy - Drug Effects
(5)
Drug Synergism
(5)
Protein Kinase Inhibitors - Pharmacology
(5)
Autophagy
(4)
Gene Expression
(4)
Hepatocellular Carcinoma
(4)
Kinases
(4)
Micrornas
(4)
Phosphorylation
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging

miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model

Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance

The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies

The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma

MicroRNAs Patterns as Potential Tools for Diagnostic and Prognostic Follow-Up in Cancer Survivorship

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation

A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin

Adenosine receptors and cancer

SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient

Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments

Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells

Cannabinoid CB2 receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia

Abstract A34: Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL)

The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy

A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin

Abstract B46: Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation

The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells

PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia

Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia

Abstract 3736: The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway

Retracted: Cannabinoid CB 2 receptors modulate ERK‐1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide

Aktive Filter

Suchergebnisse filtern